CC
Casdin Capital Portfolio holdings
AUM
$1.1B
1-Year Return
24.98%
This Quarter Return
-13.03%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$4.01B
AUM Growth
+$69M
(+1.8%)
Cap. Flow
+$681M
Cap. Flow
% of AUM
16.99%
Top 10 Holdings %
Top 10 Hldgs %
52.72%
Holding
62
New
7
Increased
9
Reduced
7
Closed
8
Top Buys
| 1 |
MaxCyte
MXCT
|
+$171M |
| 2 |
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
|
+$154M |
| 3 |
Absci
ABSI
|
+$89.8M |
| 4 |
Ginkgo Bioworks
DNA
|
+$83.5M |
| 5 |
Pacific Biosciences
PACB
|
+$76.4M |
Top Sells
| 1 |
AMRS
Amyris Inc.
AMRS
|
+$49.1M |
| 2 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
+$45.3M |
| 3 |
NeoGenomics
NEO
|
+$22.1M |
| 4 |
Fulcrum Therapeutics
FULC
|
+$12.1M |
| 5 |
Clover Health Investments
CLOV
|
+$9.68M |
Sector Composition
| 1 | Healthcare | 91.34% |
| 2 | Materials | 0% |
